All In MedTech

Device Trial Radar · NCT03791970

Stents Post-dilation With DCB or POBA in Femoropopliteal Arteries

A Prospective, Single Center, Case-cohort Study Using the Orchid Drug Coated Balloon for Post-Dilatation of the Stent for Treatment of Long Lesions in Femoropopliteal Arteries

Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Jan 1, 2019

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Sponsor type
Academic, hospital or other
First posted
Jan 3, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare the efficacy and safety of stent angioplasty with Orchid 035 Drug Coated Dilatation (DCB) and Plain Old Balloon Angioplasty (POBA) for post-dilatation for long (\>10cm) femoropopliteal chronic total occlusion.

Conditions

  • Peripheral Artery Disease

Interventions

  • Orchid 035 DCB CatheterDevice

    Stents placement for femoropopliteal arterial occlusions following with Orchid 035 DCB Catheter for post-dilation

  • POBA CatheterDevice

    Stents placement for femoropopliteal arterial occlusions following with POBA for post-dilation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary patency rateTime frame: 12 months post-procedure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Kaichuang Ye

    Shanghai, Shanghai Municipality, China · Recruiting

  • Minyi Yin

    Shanghai, Shanghai Municipality, China · Recruiting

  • Xiaobing Liu

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.